Skip to Content

APO 020 (Omeprazole delayed release 20 mg)

Pill imprint APO 020 has been identified as Omeprazole delayed release 20 mg.

Omeprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Omeprazole delayed release 20 mg APO 020
Omeprazole delayed release 20 mg APO 020 Front
Omeprazole delayed release 20 mg APO 020 Back
Omeprazole delayed release 20 mg APO 020
Omeprazole delayed release 20 mg APO 020
Omeprazole delayed release
APO 020
20 mg
Pink / Red
18.00 mm
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Apotex Corp.
National Drug Code (NDC):
Inactive Ingredients:
magnesium hydroxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
povidone k30
triethyl citrate
ferric oxide red
titanium dioxide
ferrosoferric oxide
isopropyl alcohol
butyl alcohol
potassium hydroxide
propylene glycol

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60505-3952 Apotex Corp.
00904-5684 Major Pharmaceuticals
43063-0212 PDRX Pharmaceuticals Inc (repackager)
33261-0087 Aidarex Pharmacuticals, LLC (repackager)
68387-0370 Keltman Pharmaceuticals Inc (repackager)
55289-0971 PDRX Pharmaceuticals Inc (repackager)
66336-0706 Dispensing Solutions Inc. (repackager)
21695-0098 Rebel Distributors Corp (repackager)
16590-0176 Stat RX USA LLC (repackager)
54569-5482 A-S Medication Solutions, LLC (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.